| Cysteinyl leukotrienes and their receptors: molecular and functional characteristics RK Singh, S Gupta, S Dastidar, A Ray Pharmacology 85 (6), 336-349, 2010 | 283 | 2010 |
| Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer's disease D Goyal, SA Ali, RK Singh Progress in Neuro-Psychopharmacology and Biological Psychiatry 106, 110112, 2021 | 148 | 2021 |
| A review on leukotrienes and their receptors with reference to asthma RK Singh, R Tandon, SG Dastidar, A Ray Journal of Asthma 50 (9), 922-931, 2013 | 147 | 2013 |
| Cysteine cathepsin S as an immunomodulatory target: present and future trends S Gupta, RK Singh, S Dastidar, A Ray Expert opinion on therapeutic targets 12 (3), 291-299, 2008 | 119 | 2008 |
| Role of toll‐like receptors in modulation of cytokine storm signaling in SARS‐CoV‐2‐induced COVID‐19 M Manik, RK Singh Journal of medical virology 94 (3), 869-877, 2022 | 110 | 2022 |
| Neurotoxic effects of aluminium exposure as a potential risk factor for Alzheimer’s disease M Dey, RK Singh Pharmacological Reports 74 (3), 439-450, 2022 | 48 | 2022 |
| Biological Functions and Role of Mitogen-Activated Protein Kinase Activated Protein Kinase 2 (MK2) in Inflammatory Diseases RK Singh, AK Najmi, SG Dastidar Pharmacological Reports 69 (4), 746-756, 2017 | 47 | 2017 |
| A novel therapeutic potential of cysteinyl leukotrienes and their receptors modulation in the neurological complications associated with Alzheimer's disease SO Rahman, RK Singh, S Hussain, M Akhtar, AK Najmi European Journal of Pharmacology 842, 208-220, 2019 | 34 | 2019 |
| Novel therapeutic potential of mitogen-activated protein kinase activated protein kinase 2 (MK2) in chronic airway inflammatory disorders RK Singh, AK Najmi Current Drug Targets 20 (4), 367-379, 2019 | 22 | 2019 |
| Differential effect of p38 and MK2 kinase inhibitors on the inflammatory and toxicity biomarkers in vitro RK Singh, M Diwan, SG Dastidar, AK Najmi Human & experimental toxicology 37 (5), 521-531, 2018 | 21 | 2018 |
| Effect of seedlings age and number of seedlings hill− 1 on the yield of rice in a sodic soil K Prasad, R Singh, S Sheer Curr. Agric 16, 67-70, 1992 | 20 | 1992 |
| Possible Therapeutic Potential of Cysteinyl Leukotriene Receptor Antagonist Montelukast in Treatment of SARS-CoV-2-Induced COVID-19 M Dey, RK Singh Pharmacology, 1-8, 2021 | 18 | 2021 |
| Effect of fertilizer industrial effluent on the behaviour and morphology of fresh water catfish Heteropeneustes fossilis (Bloch). A Yadav, S Neraliya, R Singh | 18 | 2005 |
| BACE1: a key regulator in Alzheimer’s disease progression and current development of its inhibitors S Patel, AV Bansoad, R Singh, GL Khatik Current Neuropharmacology 20 (6), 1174, 2022 | 17 | 2022 |
| Recent trends in the management of Alzheimer’s disease: current therapeutic options and drug repurposing approaches RK Singh Current Neuropharmacology 18 (9), 868-882, 2020 | 17 | 2020 |
| Chronic oral exposure of aluminum chloride in rat modulates molecular and functional neurotoxic markers relevant to Alzheimer’s disease M Dey, RK Singh Toxicology Mechanisms and Methods 32 (8), 616-627, 2022 | 14 | 2022 |
| The clinical correlation of proinflammatory and anti-inflammatory biomarkers with Alzheimer disease: a meta-analysis U Anuradha, A Kumar, RK Singh Neurological sciences 43 (1), 285-298, 2022 | 14 | 2022 |
| Targeted delivery of montelukast for treatment of Alzheimer's disease AK Datusalia, G Singh, N Yadav, S Gaun, M Manik, RK Singh CNS & neurological disorders drug targets, 2021 | 11 | 2021 |
| Pharmacological and pathological relevance of S100 proteins in neurological disorders D Goswami, U Anuradha, A Angati, N Kumari, RK Singh CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2024 | 10 | 2024 |
| Antagonism of cysteinyl leukotrienes and their receptors as a neuroinflammatory target in Alzheimer’s disease RK Singh Neurological Sciences 41, 2081-2093, 2020 | 9 | 2020 |
Mangaldeep DeyPh.D. NIPER-RaebareliVerified email at niperrbl.ac.in
